The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adenosine and substrates containing the recognition sequence display positive cooperativity, while a type I inhibitor, PS653, displays negative cooperativity [50].”
From Allosteric binding cooperativity in kinases signaling, signalopathies, and drug development (2025) · cites this paper as [50]
In the citing paper
“The binding mode of adenosine and PS653 to PDK1 is similar, suggesting that conformational dynamics might be responsible for switching these ligands’ positive to negative binding cooperativity with substrates.”
From Allosteric binding cooperativity in kinases signaling, signalopathies, and drug development (2025) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor
Zhang, X., Gureasko, J., Shen, K., Cole, P. A., & Kuriyan, J. (2006) · Cell · doi:10.1016/j.cell.2006.05.013 · Cited by 1,650 · cited 1×
“Furthermore, epidermal growth factor receptor kinases are activated by dimerization; an activating kinase interacts with a receiver kinase at a site equivalent to the PIF pocket (Zhang et al., 2006).”
BackgroundFrödin, M., Antal, T. L., Dümmler, B. A., Jensen, C. J., Deak, M., Gammeltoft, S., & Biondi, R. M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf551 · Cited by 275
Self-citationDynamics connect substrate recognition to catalysis in protein kinase A
Masterson, L. R., Cheng, C., Yu, T., Tonelli, M., Kornev, A., Taylor, S. S., & Veglia, G. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.452 · Cited by 216
Fang, Z., Grütter, C., & Rauh, D. (2013) · ACS Chemical Biology · doi:10.1021/cb300663j · Cited by 197
Unraveling structural mechanisms of allosteric drug action
Nussinov, R., & Tsai, C.-J. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.03.006 · Cited by 119 · cited 1×
“The formulations for the allosteric conformational changes have been studied over the last 50 years (Fenton, 2008; Monod et al., 1965; Nussinov and Tsai, 2014; Weber, 1972).”
BackgroundSynchronous opening and closing motions are essential for camp-dependent protein kinase a signaling
Srivastava, A. K., McDonald, L. R., Cembran, A., Kim, J., Masterson, L. R., McClendon, C. L., Taylor, S. S., & Veglia, G. (2014) · Structure · doi:10.1016/j.str.2014.09.010 · Cited by 71
Kim, J., Masterson, L. R., Cembran, A., Verardi, R., Shi, L., Gao, J., Taylor, S. S., & Veglia, G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502299112 · Cited by 45
Research works printed but not linked: 52
- Arencibia, 2013, AGC protein kinases: from structural mechanism of regulation to allosteric drug development for the treatment of human diseases, Biochim. Biophys. Acta, 1834, 1302, 10.1016/j.bbapap.2013.03.010 · DOI · Paper page
- Axten, 2010, Preparation of 6-(4-pyrimidinyl)-1H-indazole derivatives as PDK1 inhibitors, Patent Application Number
- Bauer, 2012, Regulation of protein kinase C-related protein kinase 2 (PRK2) by an intermolecular PRK2-PRK2 interaction mediated by its N-terminal domain, J. Biol. Chem., 287, 20590, 10.1074/jbc.M111.327437 · DOI
- Bayascas, 2008, Dissecting the role of the 3-phosphoinositide-dependent protein kinase-1 (PDK1) signalling pathways, Cell Cycle, 7, 2978, 10.4161/cc.7.19.6810 · DOI
- Bayliss, 2003, Structural basis of Aurora-A activation by TPX2 at the mitotic spindle, Mol. Cell, 12, 851, 10.1016/S1097-2765(03)00392-7 · DOI · Paper page
- Best, 2009, Optimized molecular dynamics force fields applied to the helix-coil transition of polypeptides, J. Phys. Chem. B, 113, 9004, 10.1021/jp901540t · DOI · Paper page
- Biondi, 2004, Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation, Trends Biochem. Sci., 29, 136, 10.1016/j.tibs.2004.01.005 · DOI
- Biondi, 2000, Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA, EMBO J., 19, 979, 10.1093/emboj/19.5.979 · DOI · Paper page
- Biondi, 2001, The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB, EMBO J., 20, 4380, 10.1093/emboj/20.16.4380 · DOI · Paper page
- Bonomi, 2010, Enhanced sampling in the well-tempered ensemble, Phys. Rev. Lett., 104, 190601, 10.1103/PhysRevLett.104.190601 · DOI · Paper page
- Borea, 2016, Adenosine as a multi-signalling guardian angel in human diseases: when, where and how does it exert its protective effects?, Trends Pharmacol. Sci., 37, 419, 10.1016/j.tips.2016.02.006 · DOI · Paper page
- Bray, 2004, Conformational spread: the propagation of allosteric states in large multiprotein complexes, Annu. Rev. Biophys. Biomol. Struct., 33, 53, 10.1146/annurev.biophys.33.110502.132703 · DOI · Paper page
- Brockmann, 2013, Small molecule inhibitors of aurora-A induce proteasomal degradation of N-Myc in childhood neuroblastoma, Cancer Cell, 30, 357, 10.1016/j.ccell.2016.07.002 · DOI
- Busschots, 2012, Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site, Chem. Biol., 19, 1152, 10.1016/j.chembiol.2012.07.017 · DOI
- Cameron, 2009, PKC maturation is promoted by nucleotide pocket occupation independently of intrinsic kinase activity, Nat. Struct. Mol. Biol., 16, 624, 10.1038/nsmb.1606 · DOI
- Changeux, 2012, Allostery and the Monod-Wyman-Changeux model after 50 years, Annu. Rev. Biophys., 41, 103, 10.1146/annurev-biophys-050511-102222 · DOI · Paper page
- Collins, 2003, In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation, EMBO J., 22, 4202, 10.1093/emboj/cdg407 · DOI · Paper page
- Conn, 2014, Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders, Nat. Rev. Drug Discov., 13, 692, 10.1038/nrd4308 · DOI · Paper page
- Dolker, 2014, The SH2 domain regulates c-Abl kinase activation by a cyclin-like mechanism and remodulation of the hinge motion, PLoS Comput. Biol., 10, e1003863, 10.1371/journal.pcbi.1003863 · DOI
- Engel, 2006, Allosteric activation of the protein kinase PDK1 with low molecular weight compounds, EMBO J., 25, 5469, 10.1038/sj.emboj.7601416 · DOI
- Fenton, 2008, Allostery: an illustrated definition for the 'second secret of life', Trends Biochem. Sci., 33, 420, 10.1016/j.tibs.2008.05.009 · DOI · Paper page
- Goodey, 2008, Allosteric regulation and catalysis emerge via a common route, Nat. Chem. Biol., 4, 474, 10.1038/nchembio.98 · DOI · Paper page
- Gray, 2014, Discovery of allosteric BCR-ABL inhibitors from phenotypic screen to clinical candidate, Methods Enzymol., 548, 173, 10.1016/B978-0-12-397918-6.00007-0 · DOI
- Gustafson, 2014, Drugging MYCN through an allosteric transition in Aurora kinase A, Cancer Cell, 26, 414, 10.1016/j.ccr.2014.07.015 · DOI · Paper page
- Heidorn, 2010, Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF, Cell, 140, 209, 10.1016/j.cell.2009.12.040 · DOI · Paper page
- Herbert, 2013, Molecular mechanism of SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signaling, Cancer Cell, 23, 489, 10.1016/j.ccr.2013.02.018 · DOI
- Hess, 2008, GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation, J. Chem. Theory Comput., 4, 435, 10.1021/ct700301q · DOI · Paper page
- Hindie, 2009, Structure and allosteric effects of low molecular weight activators on the protein kinase PDK1, Nat. Chem. Biol., 5, 758, 10.1038/nchembio.208 · DOI
- Johnson, 2001, Dynamics of cAMP-dependent protein kinase, Chem. Rev., 101, 2243, 10.1021/cr000226k · DOI · Paper page
- Komander, 2003, Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition, Biochem. J., 375, 255, 10.1042/bj20031119 · DOI
- Kornev, 2015, Dynamics-driven allostery in protein kinases, Trends Biochem. Sci., 40, 628, 10.1016/j.tibs.2015.09.002 · DOI · Paper page
- Kornev, 2006, Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism, Proc. Natl. Acad. Sci. USA, 03, 17783, 10.1073/pnas.0607656103 · DOI · Paper page
- Kuriyan, 2007, The origin of protein interactions and allostery in colocalization, Nature, 450, 983, 10.1038/nature06524 · DOI · Paper page
- Lindorff-Larsen, 2010, Improved side-chain torsion potentials for the Amber ff99SB protein force field, Proteins, 78, 1950, 10.1002/prot.22711 · DOI · Paper page
- Monod, 1965, On the nature of allosteric transitions: a plausible model, J. Mol. Biol., 12, 88, 10.1016/S0022-2836(65)80285-6 · DOI · Paper page
- Nagar, 2003, Structural basis for the autoinhibition of c-Abl tyrosine kinase, Cell, 112, 859, 10.1016/S0092-8674(03)00194-6 · DOI · Paper page
- Najafov, 2011, Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1, Biochem. J., 433, 357, 10.1042/BJ20101732 · DOI
- Nussinov, 2013, Allostery in disease and in drug discovery, Cell, 153, 293, 10.1016/j.cell.2013.03.034 · DOI · Paper page
- Rettenmaier, 2014, A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1, Proc. Natl. Acad. Sci. USA, 111, 18590, 10.1073/pnas.1415365112 · DOI
- Sadowsky, 2011, Turning a protein kinase on or off from a single allosteric site via disulfide trapping, Proc. Natl. Acad. Sci. USA, 108, 6056, 10.1073/pnas.1102376108 · DOI
- Saladino, 2012, New insights in protein kinase conformational dynamics, Curr. Top. Med. Chem., 12, 1889, 10.2174/156802612804547407 · DOI
- Stockman, 2009, Identification of allosteric PIF-pocket ligands for PDK1 using NMR-based fragment screening and 1H-15N TROSY experiments, Chem. Biol. Drug Des., 73, 179, 10.1111/j.1747-0285.2008.00768.x · DOI
- Sugita, 1999, Replica-exchange molecular dynamics method for protein folding, Chem. Phys. Lett., 314, 141, 10.1016/S0009-2614(99)01123-9 · DOI · Paper page
- Takahashi, 1989, UCN-01 and UCN-02, new selective inhibitors of protein kinase C. I. Screening, producing organism and fermentation, J. Antibiot. (Tokyo), 42, 564, 10.7164/antibiotics.42.564 · DOI
- Taylor, 2012, Assembly of allosteric macromolecular switches: lessons from PKA, Nat. Rev. Mol. Cell Biol., 13, 646, 10.1038/nrm3432 · DOI · Paper page
- Tribello, 2014, PLUMED 2: new feathers for an old bird, Computer Phys. Commun., 185, 604, 10.1016/j.cpc.2013.09.018 · DOI · Paper page
- Wang, 2012, Divergent allosteric control of the IRE1alpha endoribonuclease using kinase inhibitors, Nat. Chem. Biol., 8, 982, 10.1038/nchembio.1094 · DOI · Paper page
- Weber, 1972, Ligand binding and internal equilibria in proteins, Biochemistry, 11, 864, 10.1021/bi00755a028 · DOI · Paper page
- Wei, 2010, Design and synthesis of benzoazepin-2-one analogs as allosteric binders targeting the PIF pocket of PDK1, Bioorg. Med. Chem. Lett., 20, 3897, 10.1016/j.bmcl.2010.05.019 · DOI
- Wojcik, 2010, A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain, Nat. Struct. Mol. Biol., 17, 519, 10.1038/nsmb.1793 · DOI · Paper page
- Yang, 2002, Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation, Mol. Cell, 9, 1227, 10.1016/S1097-2765(02)00550-6 · DOI · Paper page
- Zheng, 1993, Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor, Biochemistry, 32, 2154, 10.1021/bi00060a005 · DOI · Paper page
Cited by
Verkhivker, G. M., Agajanian, S., Hu, G., & Tao, P. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00136 · Cited by 76
Allosteric binding cooperativity in kinases signaling, signalopathies, and drug development
Olivieri, C., Wu, J., Taylor, S. S., & Veglia, G. (2025) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2025.103169 · Cited by 1
Metadata
- Authors
- Schulze, J. O., Saladino, G., Busschots, K., Neimanis, S., Süß, E., Odadzic, D., Zeuzem, S., Hindie, V., Herbrand, A. K., Lisa, M.-N., Alzari, P. M., Gervasio, F. L., & Biondi, R. M.
- Venue
- Cell Chemical Biology
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 23
- Issue
- 10
- Pages
- 1193-1205
- ISSN
- 2451-9456
- Cited by
- 86
- References
- 7
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 384 d)
- Funders
- E-Infrastructure South (Emerald)
- HEC-BioSim (Archer)
- PRACE Research Infrastructure
- MareNostrum, Curie and Hornet (FP7/2007-2013)
- BMBF GO-Bio (0315102)
- DFG (BI 1044/2-3, BI 1044/12-1)
- Engineering and Physical Sciences Research Council (EP/M013898/1)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.